Northland analyst Michael Latimore raised the firm’s price target on DocGo to $16 from $15 and keeps an Outperform rating on the shares. The firm is increasing its second half revenue and EBITDA estimates after a “strong” Q2, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DCGO:
- DocGo raises FY23 revenue view to $540M-$550M from $500M-$510M, consensus $504M
- DocGo reports Q2 EPS (2c), consensus 3c
- DCGO Upcoming Earnings Report: What to Expect?
- DocGo to participate in a conference call with Northland
- Stifel not surprised by issues, critics of DocGo execution of relocation contract
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue